Literature DB >> 24614765

Gastrointestinal issues in autism spectrum disorder.

Elaine Y Hsiao1.   

Abstract

While autism spectrum disorder (ASD) is characterized by communication impairments, social abnormalities, and stereotypic behaviors, several medical comorbidities are observed in autistic individuals. Of these, gastrointestinal (GI) abnormalities are of particular interest given their reported prevalence and correlation with the severity of core autism-related behavioral abnormalities. This review discusses the GI pathologies seen in ASD individuals and the association of particular GI conditions with known genetic and environmental risk factors for autism. It further addresses how GI abnormalities can affect the neuropathological and behavioral features of ASD, as well as the development of autism-related endophenotypes such as immune dysregulation, hyperserotonemia, and metabolic dysfunction. Finally, it presents emerging evidence for a gut-brain connection in autism, wherein GI dysfunction may contribute to the pathogenesis or severity of ASD symptoms.

Entities:  

Mesh:

Year:  2014        PMID: 24614765     DOI: 10.1097/HRP.0000000000000029

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  54 in total

Review 1.  Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

Authors:  Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

Review 2.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 3.  Natural products as mediators of disease.

Authors:  Neha Garg; Tal Luzzatto-Knaan; Alexey V Melnik; Andrés Mauricio Caraballo-Rodríguez; Dimitrios J Floros; Daniel Petras; Rachel Gregor; Pieter C Dorrestein; Vanessa V Phelan
Journal:  Nat Prod Rep       Date:  2016-11-22       Impact factor: 13.423

Review 4.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 5.  Interactions of innate and adaptive immunity in brain development and function.

Authors:  Anthony J Filiano; Sachin P Gadani; Jonathan Kipnis
Journal:  Brain Res       Date:  2014-08-07       Impact factor: 3.252

Review 6.  Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance.

Authors:  Mohtashem Samsam; Raheleh Ahangari; Saleh A Naser
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 7.  Sleep Disorder, Gastrointestinal Problems and Behaviour Problems Seen in Autism Spectrum Disorder Children and Yoga as Therapy: A Descriptive Review.

Authors:  Kumar Narasingharao; Balaram Pradhan; Janardhana Navaneetham
Journal:  J Clin Diagn Res       Date:  2016-11-01

8.  The prevalence of gluten free diet use among preschool children with autism spectrum disorder.

Authors:  Eric Rubenstein; Laura Schieve; Chyrise Bradley; Carolyn DiGuiseppi; Eric Moody; Kathleen Thomas; Julie Daniels
Journal:  Autism Res       Date:  2017-11-20       Impact factor: 5.216

9.  Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function.

Authors:  Kara Gross Margolis; Zhishan Li; Korey Stevanovic; Virginia Saurman; Narek Israelyan; George M Anderson; Isaac Snyder; Jeremy Veenstra-VanderWeele; Randy D Blakely; Michael D Gershon
Journal:  J Clin Invest       Date:  2016-04-25       Impact factor: 14.808

Review 10.  Cannabidiol and Neurodevelopmental Disorders in Children.

Authors:  Keith A Kwan Cheung; Murray D Mitchell; Helen S Heussler
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.